NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $371,000 | -31.5% | 7,212 | -1.9% | 0.00% | – |
| Q1 2022 | $542,000 | -48.4% | 7,353 | +0.1% | 0.00% | -100.0% |
| Q4 2021 | $1,051,000 | -30.0% | 7,348 | +1.5% | 0.00% | 0.0% |
| Q3 2021 | $1,501,000 | -1.8% | 7,241 | +0.6% | 0.00% | 0.0% |
| Q2 2021 | $1,528,000 | +15.8% | 7,198 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $1,320,000 | +61.2% | 7,278 | -0.9% | 0.00% | 0.0% |
| Q4 2020 | $819,000 | +5.0% | 7,347 | +2.1% | 0.00% | 0.0% |
| Q3 2020 | $780,000 | +30.0% | 7,197 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $600,000 | – | 7,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |